secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocugen, Inc. (OCGN)
CIK:        0001372299
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001104659-24-084689
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocugen prices $35M public offering of 30.4M shares at $1.15 per share
---------------------------------------------------------------------

- Gross proceeds of $35M; net proceeds expected ~$32.6M after underwriting discounts.
- Underwriter granted 30-day option to purchase up to 4,565,217 additional shares at same price.
- Proceeds to be used for general corporate purposes, working capital, and G&A expenses.
- Offering expected to close on or about August 2, 2024; Titan Partners Group sole book-runner.
- Financing led by a premier mutual fund with participation from leading life sciences investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/0001104659-24-084689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/tm2420013d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-084689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer